Ventas, Inc. (VTR)
NYSE: VTR · Real-Time Price · USD
81.38
-0.64 (-0.78%)
Jun 8, 2026, 9:36 AM EDT - Market open
Ventas Revenue
Ventas had revenue of $1.65B in the quarter ending March 31, 2026, with 22.19% growth. This brings the company's revenue in the last twelve months to $6.09B, up 20.69% year-over-year. In the year 2025, Ventas had annual revenue of $5.79B with 18.48% growth.
Revenue (ttm)
$6.09B
Revenue Growth
+20.69%
P/S Ratio
6.57
Revenue / Employee
$11,278,317
Employees
542
Market Cap
39.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.79B | 903.28M | 18.48% |
| Dec 31, 2024 | 4.89B | 423.64M | 9.49% |
| Dec 31, 2023 | 4.46B | 386.06M | 9.47% |
| Dec 31, 2022 | 4.08B | 339.18M | 9.07% |
| Dec 31, 2021 | 3.74B | 30.98M | 0.84% |
| Dec 31, 2020 | 3.71B | -65.33M | -1.73% |
| Dec 31, 2019 | 3.77B | 175.87M | 4.89% |
| Dec 31, 2018 | 3.60B | 146.19M | 4.24% |
| Dec 31, 2017 | 3.45B | 105.96M | 3.17% |
| Dec 31, 2016 | 3.34B | 145.76M | 4.56% |
| Dec 31, 2015 | 3.20B | 478.02M | 17.57% |
| Dec 31, 2014 | 2.72B | 260.60M | 10.59% |
| Dec 31, 2013 | 2.46B | 31.57M | 1.30% |
| Dec 31, 2012 | 2.43B | 732.53M | 43.19% |
| Dec 31, 2011 | 1.70B | 712.33M | 72.41% |
| Dec 31, 2010 | 983.74M | 74.22M | 8.16% |
| Dec 31, 2009 | 909.52M | 3.44M | 0.38% |
| Dec 31, 2008 | 906.07M | 164.80M | 22.23% |
| Dec 31, 2007 | 741.27M | 353.11M | 90.97% |
| Dec 31, 2006 | 388.17M | 77.25M | 24.85% |
| Dec 31, 2005 | 310.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Welltower | 11.77B |
| Healthpeak Properties | 2.87B |
| American Healthcare REIT | 2.37B |
| Diversified Healthcare Trust | 1.52B |
| Omega Healthcare Investors | 1.24B |
| Healthcare Realty Trust | 1.16B |
| Medical Properties Trust | 1.10B |
| Sabra Health Care REIT | 815.66M |
VTR News
- 4 days ago - Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement - Business Wire
- 6 days ago - Ventas affirms FY26 FFO view of $3.82-$3.89, consensus $3.87 - TheFly
- 6 days ago - Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor Conference - Business Wire
- 7 days ago - Ventas Slides: Investor presentation - Filings
- 13 days ago - Ventas price target raised to $110 from $102 at BofA - TheFly
- 17 days ago - Ventas price target raised to $95 from $93 at Scotiabank - TheFly
- 20 days ago - Ventas price target raised to $110 from $100 at Goldman Sachs - TheFly
- 25 days ago - Ventas Declares Quarterly Dividend of $0.52 Per Common Share - Business Wire